Improving communication about sexual health for young cancer patients
Official title: Improving Health-Related Quality of Life Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
Run by Connecticut Children's Medical Center · NCT06982066 · Data updated 2026-11-12
This study is testing a new online tool to help young cancer patients talk more openly with their doctors about sexual and reproductive health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 25 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Connecticut Children's Medical Center Academic / other |
| Drugs / interventions | Chemotherapy, immunotherapy |
| Locations | 1 site (Hartford, Connecticut) |
| Status | Recruiting |
| Started | February 10, 2025 |
| Main results expected | March 15, 2029 |
| Study ends | June 29, 2029 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT06982066 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents and young adults aged 15-25 who are currently undergoing cancer treatment.
✕Probably not a fit
Patients who are not currently receiving cancer-directed therapy or are outside the age range of 15-25 may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance communication between adolescent and young adult oncology patients and their healthcare providers regarding sexual and reproductive health. It will develop and test a web-based tool called ReSPECT, designed to facilitate these discussions in outpatient oncology settings. The intervention will be refined based on feedback from both patients and clinicians before being tested in a cohort study. Participants will complete surveys and interviews to assess the effectiveness of the intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of sexual and reproductive health communication for young cancer patients, leading to better patient outcomes.
How similar studies have gone: While there is limited data on similar interventions specifically for AYA oncology patients, the approach of enhancing patient-provider communication has shown promise in other healthcare settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Adolescent and Young Adult Oncology Patients In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Be aged 15-25 years old at time of enrollment. 2. Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following: 1. Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy. 2. Radiotherapy: any radiotherapy to treat the cancer diagnosis. 3. Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery. 3. Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later. 4. Be able to speak and read English 5. Have permission to participate from a member of the patient's primary oncology team. 6. Provision to sign and date the consent/assent form. 7. Active study participation of primary oncology clinician 8. Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute Exclusion Criteria An individual who meets and of the following criteria will be excluded from participation in this study: 1. Not currently on cancer-directed therapy. 2. Unable to speak and read English. 3. Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team) Pediatric Oncology Clinicians 1\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer
Where it's running
-
Connecticut Children's Medical Center
Hartford, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Natasha Frederick, MD, MPH — nfrederick@connecticutchildrens.org
- Study coordinator: Natasha Frederick, MD, MPH
- Email: nfrederick@connecticutchildrens.org
- Phone: 860-545-9618
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.